• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

调节性 T 细胞可减轻帕金森病模型中 Th17 细胞介导的黑质纹状体多巴胺能神经退行性变。

Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson's disease.

机构信息

Department of Pharmacology and Experimental Neuroscience, Center for Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, NE 68198, USA.

出版信息

J Immunol. 2010 Mar 1;184(5):2261-71. doi: 10.4049/jimmunol.0901852. Epub 2010 Jan 29.

DOI:10.4049/jimmunol.0901852
PMID:20118279
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2824790/
Abstract

Nitrated alpha-synuclein (N-alpha-syn) immunization elicits adaptive immune responses to novel antigenic epitopes that exacerbate neuroinflammation and nigrostriatal degeneration in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model of Parkinson's disease. We show that such neuroimmune degenerative activities, in significant measure, are Th17 cell-mediated, with CD4(+)CD25(+) regulatory T cell (Treg) dysfunction seen among populations of N-alpha-syn-induced T cells. In contrast, purified vasoactive intestinal peptide induced and natural Tregs reversed N-alpha-syn T cell nigrostriatal degeneration. Combinations of adoptively transferred N-alpha-syn and vasoactive intestinal peptide immunocytes or natural Tregs administered to MPTP mice attenuated microglial inflammatory responses and led to robust nigrostriatal protection. Taken together, these results demonstrate Treg control of N-alpha-syn-induced neurodestructive immunity and, as such, provide a sound rationale for future Parkinson's disease immunization strategies.

摘要

硝化的α-突触核蛋白(N-α-突触核蛋白)免疫会引发针对新抗原表位的适应性免疫反应,从而加剧 1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)帕金森病模型中的神经炎症和黑质纹状体变性。我们表明,这种神经免疫退行性活动在很大程度上是由 Th17 细胞介导的,在 N-α-突触核蛋白诱导的 T 细胞群体中观察到 CD4(+)CD25(+)调节性 T 细胞(Treg)功能障碍。相比之下,纯化的血管活性肠肽诱导的天然 Treg 逆转了 N-α-突触核蛋白 T 细胞黑质纹状体变性。将过继转移的 N-α-突触核蛋白和血管活性肠肽免疫细胞或天然 Treg 组合施用于 MPTP 小鼠,可减轻小胶质细胞的炎症反应,并导致黑质纹状体的显著保护。总之,这些结果表明 Treg 控制 N-α-突触核蛋白诱导的神经破坏性免疫,因此为未来的帕金森病免疫策略提供了合理的依据。

相似文献

1
Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson's disease.调节性 T 细胞可减轻帕金森病模型中 Th17 细胞介导的黑质纹状体多巴胺能神经退行性变。
J Immunol. 2010 Mar 1;184(5):2261-71. doi: 10.4049/jimmunol.0901852. Epub 2010 Jan 29.
2
Nitrated alpha-synuclein immunity accelerates degeneration of nigral dopaminergic neurons.硝化α-突触核蛋白免疫反应加速黑质多巴胺能神经元的退化。
PLoS One. 2008 Jan 2;3(1):e1376. doi: 10.1371/journal.pone.0001376.
3
Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson's disease.帕金森病动物模型中CD4+CD25+调节性T细胞的神经保护活性
J Leukoc Biol. 2007 Nov;82(5):1083-94. doi: 10.1189/jlb.0507296. Epub 2007 Aug 3.
4
Early α-synuclein/synapsin III co-accumulation, nigrostriatal dopaminergic synaptopathy and denervation in the MPTPp mouse model of Parkinson's Disease.在 MPTPp 帕金森病小鼠模型中,早期α-突触核蛋白/突触素 III 共积累、黑质纹状体多巴胺能突触病变和去神经支配。
Exp Neurol. 2025 Jan;383:115040. doi: 10.1016/j.expneurol.2024.115040. Epub 2024 Nov 3.
5
Dopamine receptor D3 expressed on CD4+ T cells favors neurodegeneration of dopaminergic neurons during Parkinson's disease.CD4+T 细胞上表达的多巴胺受体 D3 在帕金森病中有利于多巴胺能神经元的神经退行性变。
J Immunol. 2013 May 15;190(10):5048-56. doi: 10.4049/jimmunol.1203121. Epub 2013 Apr 15.
6
Novel role of aquaporin-4 in CD4+ CD25+ T regulatory cell development and severity of Parkinson's disease.水通道蛋白-4在 CD4+ CD25+ T 调节性细胞发育及帕金森病严重程度中的新作用。
Aging Cell. 2011 Jun;10(3):368-82. doi: 10.1111/j.1474-9726.2011.00677.x. Epub 2011 Mar 22.
7
Tolerogenic bone marrow-derived dendritic cells induce neuroprotective regulatory T cells in a model of Parkinson's disease.耐受原骨髓来源的树突状细胞在帕金森病模型中诱导神经保护调节性 T 细胞。
Mol Neurodegener. 2018 May 21;13(1):26. doi: 10.1186/s13024-018-0255-7.
8
Decreased inflammation and augmented expression of trophic factors correlate with MOG-induced neuroprotection of the injured nigrostriatal system in the murine MPTP model of Parkinson's disease.在小鼠帕金森病MPTP模型中,炎症减轻和营养因子表达增加与MOG诱导的黑质纹状体系统损伤的神经保护作用相关。
Int Immunopharmacol. 2009 Jun;9(6):781-91. doi: 10.1016/j.intimp.2009.03.003. Epub 2009 Mar 13.
9
GM-CSF induces neuroprotective and anti-inflammatory responses in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxicated mice.GM-CSF 诱导 1-甲基-4-苯基-1,2,3,6-四氢吡啶中毒小鼠产生神经保护和抗炎反应。
J Neuroimmunol. 2013 Dec 15;265(1-2):1-10. doi: 10.1016/j.jneuroim.2013.10.009. Epub 2013 Oct 29.
10
Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration.向大鼠脑内纹状体注射预先形成的小鼠α-突触核蛋白原纤维会引发α-突触核蛋白病变和双侧黑质纹状体变性。
Neurobiol Dis. 2015 Oct;82:185-199. doi: 10.1016/j.nbd.2015.06.003. Epub 2015 Jun 17.

引用本文的文献

1
The role of T cells in the treatment of Parkinson's disease.T细胞在帕金森病治疗中的作用。
PeerJ. 2025 Aug 14;13:e19818. doi: 10.7717/peerj.19818. eCollection 2025.
2
Adaptive immunity in the pathogenesis and treatments of Parkinson's disease.适应性免疫在帕金森病发病机制及治疗中的作用
NeuroImmune Pharm Ther. 2025 Jun 20;4(2):273-284. doi: 10.1515/nipt-2025-0008. eCollection 2025 Jun.
3
The role of interleukin-17 in neurological disorders.白细胞介素-17在神经疾病中的作用。
Anim Cells Syst (Seoul). 2025 Jun 3;29(1):372-386. doi: 10.1080/19768354.2025.2510994. eCollection 2025.
4
Construction and Identification of Inflammation-Related TF-mRNA-miRNA Coexpression Network and Immune Infiltration in Parkinson's Disease.帕金森病中炎症相关转录因子-信使核糖核酸-微小核糖核酸共表达网络的构建与鉴定及免疫浸润
Parkinsons Dis. 2025 May 7;2025:2323585. doi: 10.1155/padi/2323585. eCollection 2025.
5
Alzheimer's disease and the immune system: A comprehensive overview with a focus on B cells, humoral immunity, and immunotherapy.阿尔茨海默病与免疫系统:聚焦B细胞、体液免疫和免疫疗法的全面综述
J Alzheimers Dis Rep. 2025 Apr 27;9:25424823251329188. doi: 10.1177/25424823251329188. eCollection 2025 Jan-Dec.
6
α-Synuclein orchestrates Th17 responses as antigen and adjuvant in Parkinson's disease.α-突触核蛋白在帕金森病中作为抗原和佐剂调控辅助性T细胞17反应。
J Neuroinflammation. 2025 Feb 11;22(1):38. doi: 10.1186/s12974-025-03359-w.
7
The Interplay of Stress, Inflammation, and Metabolic Factors in the Course of Parkinson's Disease.应激、炎症和代谢因素在帕金森病病程中的相互作用。
Int J Mol Sci. 2024 Nov 19;25(22):12409. doi: 10.3390/ijms252212409.
8
Repetitive transcranial magnetic stimulation alleviates motor impairment in Parkinson's disease: association with peripheral inflammatory regulatory T-cells and SYT6.重复经颅磁刺激可缓解帕金森病的运动障碍:与外周炎症调节性 T 细胞和 SYT6 相关。
Mol Neurodegener. 2024 Oct 25;19(1):80. doi: 10.1186/s13024-024-00770-4.
9
An in-depth understanding of the role and mechanisms of T cells in immune organ aging and age-related diseases.深入了解T细胞在免疫器官衰老及与年龄相关疾病中的作用和机制。
Sci China Life Sci. 2025 Feb;68(2):328-353. doi: 10.1007/s11427-024-2695-x. Epub 2024 Sep 2.
10
Differentiation and regulation of CD4 T cell subsets in Parkinson's disease.帕金森病中 CD4 T 细胞亚群的分化与调控。
Cell Mol Life Sci. 2024 Aug 17;81(1):352. doi: 10.1007/s00018-024-05402-0.

本文引用的文献

1
Proteomic studies of nitrated alpha-synuclein microglia regulation by CD4+CD25+ T cells.CD4+CD25+ T细胞对硝化α-突触核蛋白小胶质细胞调节的蛋白质组学研究
J Proteome Res. 2009 Jul;8(7):3497-511. doi: 10.1021/pr9001614.
2
Nitrated {alpha}-synuclein-induced alterations in microglial immunity are regulated by CD4+ T cell subsets.硝化α-突触核蛋白诱导的小胶质细胞免疫改变受CD4 + T细胞亚群调节。
J Immunol. 2009 Apr 1;182(7):4137-49. doi: 10.4049/jimmunol.0803982.
3
Neuromodulatory activities of CD4+CD25+ regulatory T cells in a murine model of HIV-1-associated neurodegeneration.HIV-1 相关神经变性小鼠模型中 CD4+CD25+ 调节性 T 细胞的神经调节活性
J Immunol. 2009 Mar 15;182(6):3855-65. doi: 10.4049/jimmunol.0803330.
4
Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease.在帕金森病小鼠模型中,人α-突触核蛋白的靶向过表达引发小胶质细胞活化和适应性免疫反应。
J Neuropathol Exp Neurol. 2008 Dec;67(12):1149-58. doi: 10.1097/NEN.0b013e31818e5e99.
5
IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells.白细胞介素-6通过抑制常规T细胞向Foxp3 +调节性T细胞的转化来控制体内的辅助性T细胞17免疫反应。
Proc Natl Acad Sci U S A. 2008 Nov 25;105(47):18460-5. doi: 10.1073/pnas.0809850105. Epub 2008 Nov 17.
6
The promise and perils of an Alzheimer disease vaccine: a video debate.
J Neuroimmune Pharmacol. 2009 Mar;4(1):1-3. doi: 10.1007/s11481-008-9132-4.
7
Interplay between effector Th17 and regulatory T cells.效应性Th17细胞与调节性T细胞之间的相互作用。
J Clin Immunol. 2008 Nov;28(6):660-70. doi: 10.1007/s10875-008-9239-7. Epub 2008 Sep 23.
8
Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice.G93A-SOD1 型肌萎缩侧索硬化症小鼠中的适应性免疫神经保护作用
PLoS One. 2008 Jul 23;3(7):e2740. doi: 10.1371/journal.pone.0002740.
9
Induction of immunologic tolerance to myelin basic protein prevents central nervous system autoimmunity and improves outcome after stroke.诱导对髓鞘碱性蛋白的免疫耐受可预防中枢神经系统自身免疫,并改善中风后的预后。
Stroke. 2008 May;39(5):1575-82. doi: 10.1161/STROKEAHA.107.501486. Epub 2008 Mar 6.
10
Progress in the active immunotherapeutic approach to Alzheimer's disease: clinical investigations into AN1792-associated meningoencephalitis.阿尔茨海默病主动免疫治疗方法的进展:与AN1792相关的脑膜脑炎的临床研究
Neurodegener Dis. 2008;5(3-4):194-6. doi: 10.1159/000113700. Epub 2008 Mar 6.